Friday, November 08
|
Session Title |
Speaker(s) |
Presentation Format |
3:00 PM - 4:30 PM
|
Physician Health and Wellness: Advocating for Ourselves
MOC/CME
Provider health and wellness involves multiple issues, including provider stress, burnout and depression, which can lead to medical errors, early retirement, addiction, divorce and suicide. It has been shown that burnout issues start in medical school and progress through residency, fellowship and throughout a provider’s career. Many medical schools, residencies and allergy/immunology fellowships do not spend a lot of time on this issue during training, and, given the modern health care climate, physician/provider health and wellness is likely to continue becoming a more significant issue. This symposium will review the scientific literature about provider health and wellness and discuss the major causes of provider burnout and stress, along with potential solutions to alleviate this burden. Specific data regarding this topic among allergists/immunologists will be reviewed. This session can help allergy/immunology providers throughout their careers.
Moderators: Travis A. Miller, MD, FACAAI, and Andrew Nickels, MD, FACAAI
3:00 pm
Welcome and Introductions
Travis A. Miller, MD, FACAAI
Andrew Nickels, MD
3:05 pm
Compare and Contrast Potential Solutions to Provider Stress and Burnout, Specifically With Regards to Allergy and Immunology Providers
Maeve O'Connor, MD, FACAAI
3:30 pm
Health and Wellness Among Allergists and Immunologists: What Does the Data Show?
Gailen D. Marshall Jr., MD, PhD, FACAAI
3:55 pm
Ways to Reduce Burnout and Stress in the Practice Setting
Anil Nanda, MD, FACAAI
4:20 pm
Questions and Discussion
|
|
Travis A. Miller, MD, FACAAI
Andrew Nickels, MD
Maeve E. O'Connor, MD, FACAAI
Gailen D. Marshall, MD, PhD, FACAAI
Anil Nanda, MD, FACAAI
|
Symposium
|
Saturday, November 09
|
Session Title |
Speaker(s) |
Presentation Format |
10:00 AM - 11:30 AM
|
When Drugs Go Wild!
ARS MOC/CME
From skin-deep to outward, this session will discuss the etiology, management and evaluation of patients with severe cutaneous drug eruptions.
Moderators: Leonard Bielory, MD, FACAAI, and Joseph A. Bellanti, MD, FACAAI
10:00 am
Welcome and Introductions
Leonard Bielory, MD, FACAAI
Joseph A. Bellanti, MD, FACAAI
10:05 am
Reactions to Targeted Therapies and Immune Modulators
Mariana C. Castells, MD, PhD, FACAAI
10:35 am
Appearance and Recognition of Cutaneous Drug Eruptions
David A. Khan, MD, FACAAI
11:05 am
Approach to the Management and Treatment of Drug Eruptions
Aleena Banerji, MD
|
|
Leonard Bielory, MD, FACAAI
Joseph A. Bellanti, MD, FACAAI
Mariana C. Castells, MD, PhD, FACAAI
David A. Khan, MD, FACAAI
Aleena Banerji, MD
|
Clinical Conundrum
|
1:00 PM - 2:30 PM
|
Evolution of Food Allergy Therapies
MOC/CME
Several new interventions are likely to be approved by the FDA in the upcoming year. These therapies have different levels of efficacy and side effects and will likely greatly impact office flow. Thus, it is imperative that allergists become more facile with their knowledge regarding these therapies.
Moderators: John J. Oppenheimer, MD, FACAAI, and Marcus Shaker, MD, MSc, FACAAI
1:00 pm
Welcome and Introductions
John J. Oppenheimer, MD, FACAAI
Marcus Shaker, MD, MSc, FACAAI
1:05 pm
Efficacy and Safety of OIT and EPIT
J. Andrew Bird, MD, FACAAI
1:30 pm
Practical Impediments to These New Therapies
Julie Wang, MD, FACAAI
1:55 pm
Food Immunotherapy 2.0: What the Future May Hold
Brian P. Vickery, MD
2:20 pm
Questions and Discussion
|
|
John J. Oppenheimer, MD, FACAAI
Marcus Shaker, MD, MSc, FACAAI
J. Andrew Bird, MD, FACAAI
Julie Wang, MD, FACAAI
Brian P. Vickery, MD
|
Symposium
|
Sunday, November 10
|
Session Title |
Speaker(s) |
Presentation Format |
8:00 AM - 9:30 AM
|
Modifying Our Approach
MOC/CME
The advent of targeted therapies and further understanding of the microbiome offer exciting opportunities for new approaches to patients with asthma and allergic conditions. However, knowledge gaps continue to exist. This session will review what we've learned, what we have yet to learn and, most importantly, what can be implemented now.
Moderator: Mark L. Corbett, MD, FACAAI
8:00 am
Welcome and Introductions
Mark L. Corbett, MD, FACAAI
8:05 am
Making Sense of New Approaches to Asthma Therapy
Paul O'Byrne, MD
8:25 am
Risk Factors for Developing Allergic Disease: Lessons From the Isle of Wright
Syed H. Arshad, MBBS, DM
8:45 am – John P. McGovern Lecture
Rewilding the Microbiome: The Importance of Ecological Approaches to Immune Health
Susan Prescott, MD, MBBS, PhD
9:05 am
Manipulating the Microbiome to Prevent or Treat Allergic Conditions
Carina Venter, PhD, RD
|
|
Mark L. Corbett, MD, FACAAI
Paul O'Byrne, MD
Syed H. Arshad, MBBS, DM
Susan Prescott, MD, PhD
Carina Venter, PhD, RD
|
Plenary Session
|
10:00 AM - 11:30 AM
|
USP 797, The Final Word – What Does It Say? What Does It Mean? What Do I Have to Do?
MOC/CME
Any allergist that mixes allergy vaccines should be following the guidance of USP 797. Recent issues, unrelated to allergy vaccine preparation, have caused the USP to alter its requirements for drug compounding. Though initially allergy mixing seemed as though it might be consumed by the “compounding” controversy, the ACAAI and others worked to demonstrate the differences between mixing allergy vaccines in an allergist’s office and the compounding of pharmaceuticals by commercial compounding companies. Although the efforts of the ACAAI Advocacy Council and others were largely successful, changes to the USP 797 requirements for the mixing of allergy vaccines did occur. This symposium will review the history of the issue, address the changes and suggest operational recommendations for implementation of these changes.
Moderators: Richard G. Gower, MD, FACAAI, and Erika Gonzalez-Reyes, MD, FACAAI
10:00 am
Welcome and Introductions
Richard G. Gower, MD, FACAAI
Erika Gonzalez-Reyes, MD, FACAAI
10:05 am
The History of USP 797 Guidance and Regulation
James L. Sublett, MD, FACAAI
10:30 am
A Review of Changes
James M Tracy, DO, FACAAI
10:55 am
Recommendations for Operationalizing the Change in Mixing
J. Allen Meadows, MD, FACAAI
11:20 am
Questions and Discussion
|
|
Richard G. Gower, MD, FACAAI
Erika Gonzalez Reyes, MD, FACAAI
James L. Sublett, MD, FACAAI
James M. Tracy, DO, FACAAI
J. Allen Meadows, MD, FACAAI
|
Symposium
|
1:00 PM - 2:30 PM
|
Recurrent Infections With Normal or Near-normal Immunoglobulins: Now What?
ARS MOC/CME
Clinicians are often presented with patients complaining of recurrent infections; however, basic workup including serum immunoglobulins and specific antibodies may fail to demonstrate evidence of any immune deficiency. This clinical conundrum will review the presentation of these causes and the diagnostic workup. Treatment may include supportive therapies, and this clinical conundrum will review treatment options.
Moderators: Sami L. Bahna, MD, DrPh, FACAAI
1:00 pm
Welcome and Introductions
Sami L. Bahna, MD, DrPh, FACAAI
1:05 pm
When Does the Infection History Support the Diagnosis of an Immune Deficiency?
Elena E. Perez, MD
1:30 pm
Beyond Hypogammaglobulinemia: Additional Workup
Lisa R. Forbes, MD
1:55 pm
Evidence-based Management Strategies
Ivan Chinn, MD
2:20 pm
Questions and Discussion
|
|
Sami L. Bahna, MD, DrPH, FACAAI
Elena E. Perez, MD
Lisa R. Forbes, MD
Ivan Chinn, MD
|
Clinical Conundrum
|
3:00 PM - 4:30 PM
|
Telemedicine for the Allergist
MOC/CME
The technology involved in telemedicine, direct-to-consumer platforms and case examples of actual technology will be discussed and reviewed. This expert presentation will spark your interest in exploring the future of telemedicine.
Moderators: Jay M. Portnoy, MD, FACAAI, and Justin C. Greiwe, MD, FACAAI
3:00 pm
Welcome and Introductions
Jay M. Portnoy, MD, FACAAI
Justin C. Greiwe, MD, FACAAI
3:05 pm
How to Get Started in Telemedicine
Jay M. Portnoy, MD, FACAAI
3:25 pm
Direct-to-consumer Telemedicine
Tania Elliott, MD, FACAAI
3:45 pm
Facilitated Telemedicine as Virtual Visits
Jennifer Shih, MD
4:05 pm
The Future of Telemedicine for Allergy
David M. Lang, MD, FACAAI
4:20 pm
Questions and Discussion
|
|
Jay M. Portnoy, MD, FACAAI
Justin C. Greiwe, MD, FACAAI
Jay M. Portnoy, MD, FACAAI
Jennifer Shih, MD
Tania Elliott, MD, FACAAI
David M. Lang, MD, FACAAI
|
Symposium
|
Monday, November 11
|
Session Title |
Speaker(s) |
Presentation Format |
9:45 AM - 11:00 AM
|
Climate Change and Natural Disasters: The Central Role of Allergists
MOC/CME
Our changing climate has impacted not only our temperatures, but the onset and duration of pollen season as well. It is important for allergists to understand the impact that climate change is having on our patients and to anticipate changes to how we provide care. Natural disasters create many challenges and are extremely disruptive to people’s lives. An often-neglected aspect of natural disasters includes the impact that flooding, fires and severe weather can have on the health of people with asthma and allergic conditions. Allergists who care for patients in natural disaster-prone areas can help them prepare for when those disasters strike.
Moderators: William K. Dolen, MD, FACAAI, and Meagan W. Shepherd, MD, FACAAI
9:45 am
Welcome and Introductions
William K. Dolen, MD, FACAAI
Meagan W. Shepherd, MD, FACAAI
9:50 am
Climate Change and the Impact on Allergic Conditions
David B. Peden , MD, FACAAI
10:10 am
When Disaster Strikes: The Health Impacts of Hurricanes, Floods and Fires
Nicholas Rider, DO
10:30 am
Be Aware and Prepare: How Allergists Can Help Patients Before Their Time of Need
Maya Gharfeh, MD, MPH
10:50 am
Questions and Discussion
|
|
William K. Dolen, MD, FACAAI
Meagan W. Shepherd, MD, FACAAI
David B. Peden, MD, FACAAI
Nicholas Rider, DO
Maya Gharfeh, MD, MPH
|
Symposium
|
11:15 AM - 12:30 PM
|
New Horizons in Chronic Rhinosinusitis
MOC/CME
This session will provide a foundation for exploring newer medical, surgical and biologic therapies for chronic rhinosinusitis (CRS) with and without nasal polyps. Etiology, diagnosis and management will be reviewed.
Moderators: Alan B. Goldsobel, MD, FACAAI, and Puneet Shroff, MD, FACAAI
11:15 am
Welcome and Introductions
Alan B. Goldsobel, MD, FACAAI
Puneet Shroff, MD, FACAAI
11:20 am
New Understanding in the Etiology and Pathogenesis of Chronic Rhinosinusitis
Jonathan A. Bernstein, MD, FACAAI
11:40 am
What's New in Medical and Surgical Management of CRS
Joseph Han, MD
Noon
The Coming Revolution of Biologics in CRS
Anju T. Peters, MD
12:20 pm
Questions and Discussion
|
|
Alan B. Goldsobel, MD, FACAAI
Puneet Shroff, MD FACAAI
Anju T. Peters, MD
Joseph Han, MD
Jonathan A. Bernstein, MD, FACAAI
|
Symposium
|